Financial Information

Consolidated Statement of Financial Position
as of December 31, 2023
Consolidated Income Statement
For the period from 1 January to 31 December 2023
Consolidated Income Statement
For the period from 1 January to 31 December 2023
Consolidated Statement of Cash Flows
for the period from 01 January to 31 December 2023
Consolidated Statement of Changes in Stockholders’ Equity
for the Period From 01 January to 31 December 2023
Guidance 2024

Expected Liquidity & Strategic Measures

The Company’s operational financing plan does not require any additional external financing to fund organic growth in the medium term. However, any strategic moves to further push growth and strengthen the Company’s competitive position or increase critical mass via potential company or product acquisitions, equity investments or extended R&D efforts will need to be considered separately. Evotec intends to achieve significant organic capacity growth as a result of its corporate strategy. The Company continued to increase investments in the expansion and development of individual locations in 2023. In Toulouse, it has started to significantly expand its capacities and to build J.POD Toulouse, France. Moreover, it is expanding the existing campus in Abingdon, Oxfordshire, UK, and construction of the new building for the planned iPSC centre in Hamburg has progressed significantly. After the completion of the first J.POD facility in North America, the Company expects the completion of the second J.POD facility in Toulouse, France in 2024. The two J.POD facilities meet the production requirements of the coming years and strengthen Evotec's position as a leading partner for drug discovery and development with revolutionary technologies.

You might be interested in...

Logo Evotec white
Evotec has the right technologies & disease understanding to meet our partners' evolving needs: a comprehensive disease knowledge at the molecular level, cutting-edge technologies & platforms to translate this expertise into effective precision medicines.